Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × BI 2536 × Clear all

NCT00376623 2022-06-21

Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer

Phase 2 Completed

96 enrolled 26 charts

Carcinoma, Non-Small-Cell Lung

NCT02211833 2014-08-08

Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung